AlphaCentric Advisors »

Ascendis Pharma AS shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.2M 4.6k 266.72

More positions owned by AlphaCentric Advisors

Gilead Sciences (GILD)
Vertex Pharmaceuticals Incorporated (VRTX)
Invitation Homes (INVH)
Astrazeneca Ord (AZN)
Roivant Sciences SHS (ROIV)
Argenx Se Sponsored Adr (ARGX)
Neurocrine Biosciences (NBIX)
Incyte Corporation (INCY)
Axsome Therapeutics (AXSM)
Apogee Therapeutics (APGE)
Euronet Worldwide (EEFT)
Aeva Technologies Com New (AEVA)
Ishares Tr Rus 1000 Val Etf (IWD)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for AlphaCentric Advisors

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
Principal Financial Group
Pictet Asset Management Holding SA
A.R. Schmeidler & Co
New York State Common Retirement Fund
Walleye Trading Advisors
Driehaus Capital Management
TD Asset Management
Q Global Advisors
Sapient Capital
Walleye Trading
Tudor Investment Corporation
Standard Life Aberdeen
Handelsbanken Fonder AB
Diversified Trust Company

View all funds holding Ascendis Pharma AS